23andMe CEO Anne Wojcicki ‘surprised and disappointed’ by board resignations: Read the memo

23andMe CEO Anne Wojcicki ‘surprised and disappointed’ by board resignations: Read the memo

Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023.  Jordan Vonderhaar | Bloomberg | Getty Images All seven independent directors of 23andMe resigned from the company’s board Tuesday, a move that CEO Anne Wojcicki said left her “surprised…

Read More
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday.  Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to…

Read More
Boar’s Head indefinitely closes Virginia plant tied to deadly listeria outbreak, discontinues liverwurst

Boar’s Head indefinitely closes Virginia plant tied to deadly listeria outbreak, discontinues liverwurst

Boar’s Head announced Friday it has indefinitely shut down a Virginia deli meat plant and discontinuing the liverwurst that is linked to a deadly multi-state listeria outbreak that also sickened dozens. In what it called a “dark moment” in the company’s history, Boar’s Head said in a Friday statement it’s indefinitely closing its plant in Jarratt, Virginia, where the…

Read More
Eli Lilly to invest .8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines,…

Read More